Research Report Covers the Vision Care Market Growth 2023

Infinium Global Research has added a new report on Vision Care Market. The report predicts the market size of Vision Care is expected to reach USD 70.0 million by 2023.

The global market for vision care was valued at around USD 54.4 billion in 2016 and is expected to reach USD 70.0 million by 2023, growing at a CAGR of around 3.7% during the forecast period of 2017e to 2023f. Vision care is defined as the anticipation or prevention of visual impairment and blindness. These are common problems among the population and will soon becoming major healthcare challenges. Vision care deals with both vision and eye related problems, and corrects refractory disorders by prescription eyeglasses and contact lenses. With growing addiction towards digital world and technological innovations, vision care products are expected to grow in quality and quantity in the coming years. High investments from major players of the market and continuous research for improving the manufacture and supply process of eyeglasses, lenses, and other eye wear is clearly encouraging the sales in this market. According to WHO statistics, in 2014 there were almost 285 million people are estimated to be visually impaired worldwide in which 39 million are blind and 246 have low vision. About 90% of the world’s visually impaired live in low-income settings. 82% of people living with blindness are aged 50 and above.

Companies profiled:

  • Valeant Pharmaceuticals International Inc.
  • Novartis AG
  • The Cooper Companies Inc.
  • SynergEyes Inc.
  • Luxottica Group S.p.A.
  • Essilor International
  • Johnson & Johnson
  • Carl Zeiss Vision
  • Seiko


Key Topics Covered:


  1. Scope of the report
  2. Executive summary
  3. Qualitative analysis
  4. Global vision care market, by product type, 2015 – 2023f
  5. Global vision care market, by distribution channel, 2015 – 2023f
  6. Global vision care market, by geography, 2015 – 2023f
  7. Company profiles



Click below to access full report @


%d bloggers like this: